We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+3.97%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$305M
AUM Growth
+$2.79M
Cap. Flow
-$5.16M
Cap. Flow %
-1.69%
Top 10 Hldgs %
10.9%
Holding
274
New
32
Increased
28
Reduced
121
Closed
37

Sector Composition

Rank Sector Weight
1 Financials 22.99%
2 Industrials 16.84%
3 Consumer Discretionary 11.25%
4 Technology 10.67%
5 Real Estate 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALOG
201
DELISTED
Analogic Corp
ALOG
$389K 0.13%
4,650
-230
-5% -$19K
LNTH icon
202
Lantheus
LNTH
$6.61B
$381K 0.13%
18,610
-1,100
-6% -$22.4K
PBI icon
203
Pitney Bowes
PBI
$2.56B
$381K 0.13%
34,080
-1,730
-5% -$20.4K
HOG icon
204
Harley-Davidson
HOG
$2.78B
$378K 0.12%
7,420
MZTI
205
The Marzetti Company
MZTI
$3.02B
$377K 0.12%
2,920
RJF icon
206
Raymond James Financial
RJF
$34.7B
$375K 0.12%
6,300
RUTH
207
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$375K 0.12%
17,320
-950
-5% -$20K
SSTK icon
208
Shutterstock
SSTK
$227M
$367K 0.12%
8,540
-480
-5% -$18.7K
MDSO
209
DELISTED
Medidata Solutions, Inc.
MDSO
$366K 0.12%
5,780
-330
-5% -$23.5K
ESNT icon
210
Essent Group
ESNT
$6.1B
$356K 0.12%
+8,200
New +$357K
EBSB
211
DELISTED
Meridian Bancorp, Inc.
EBSB
$350K 0.11%
17,000
-950
-5% -$18.8K
ANDV
212
DELISTED
Andeavor
ANDV
$348K 0.11%
3,040
+340
+13% +$36.6K
CBRL icon
213
Cracker Barrel
CBRL
$1.3B
$346K 0.11%
+2,180
New +$342K
STMP
214
DELISTED
Stamps.com, Inc.
STMP
$338K 0.11%
1,800
+590
+49% +$114K
ARRY
215
DELISTED
Array Biopharma Inc
ARRY
$327K 0.11%
25,560
-1,430
-5% -$16.3K
PCRX icon
216
Pacira BioSciences
PCRX
$986M
$297K 0.1%
6,500
-360
-5% -$14.3K
PLAY icon
217
Dave & Buster's
PLAY
$361M
$290K 0.1%
5,260
-320
-6% -$16.3K
CTMX icon
218
CytomX Therapeutics
CTMX
$721M
$289K 0.09%
13,670
-760
-5% -$15.8K
CSOD
219
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$286K 0.09%
8,090
+2,360
+41% +$88K
MYOK
220
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$280K 0.09%
+6,660
New +$257K
KYNB
221
Kyntra Bio
KYNB
$28.3M
$277K 0.09%
234
-149
-39% -$187K
FLR icon
222
Fluor
FLR
$7.06B
$251K 0.08%
4,850
TTSH
223
DELISTED
Tile Shop Holdings
TTSH
$249K 0.08%
25,980
-1,230
-5% -$10.9K
AEE icon
224
Ameren
AEE
$30.1B
$248K 0.08%
4,200
AMPH icon
225
Amphastar Pharmaceuticals
AMPH
$890M
$245K 0.08%
12,730
-760
-6% -$14.2K

Similar funds

Piermont Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Piermont Capital Management held 274 positions worth $305M, up 0.92% from $302M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Piermont Capital Management's Q4 2017 filing shows 32 new, 28 increased, 121 reduced and 37 closed positions. Its largest new stake was Brunswick: 53,300 shares worth $2.94M. The largest sale was LendingTree, an estimated $3.15M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Piermont Capital Management's largest Q4 2017 buy was Brunswick: 53,300 shares worth $2.94M.
  • Piermont Capital Management added most to Louisiana-Pacific in Q4 2017, an estimated $2.48M increase.
  • Piermont Capital Management's biggest Q4 2017 reduction was Spectrum Pharmaceuticals Inc, cutting an estimated $1.17M.
  • Piermont Capital Management fully exited LendingTree in Q4 2017, selling an estimated $3.15M.
  • Piermont Capital Management's ten largest holdings make up 11% of its $305M portfolio in Q4 2017.
  • Piermont Capital Management opened 32 new positions and closed 37 in Q4 2017.
  • Piermont Capital Management's portfolio value rose 0.92% quarter-over-quarter to $305M.

Based on Piermont Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.